Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05120947 · ClinicalTrials.gov registry record · NA
Hypofractionated Adjuvant Radiotherapy for Resected Head and Neck Cancers
A NA study, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT05120947 is a NA study that has completed, run by Medical College of Wisconsin. The registered enrollment target is 18 participants.
The verdict
NCT05120947, a NA study, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The primary purpose of this study is to determine the safe reduction of the treatment fractions to 10, 8, or 5, that may be delivered safely in resected head and neck squamous cell carcinoma (HNSCC) patients with intermediate pathologic risk features.
Interventions
- RADIATION 42 Gy Radiation Therapy
- RADIATION 39 Gy Radiation Therapy
- RADIATION 32.5 Gy Radiation Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2021-12-01 |
| Est. Completion | 2025-11-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05120947
The ClinicalTrials.gov registry entry for NCT05120947 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which 42 Gy Radiation Therapy is the first listed.
NCT05120947 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05120947 about?
NCT05120947 is a clinical study titled "Hypofractionated Adjuvant Radiotherapy for Resected Head and Neck Cancers". The primary purpose of this study is to determine the safe reduction of the treatment fractions to 10, 8, or 5, that may be delivered safely in resected head and neck squamous cell carcinoma (HNSCC) patients with intermediate pathologic risk features.
What is the current status of trial NCT05120947?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2021-12-01. Estimated completion is 2025-11-22.
What interventions are being tested in trial NCT05120947?
The interventions under investigation include: 42 Gy Radiation Therapy (RADIATION), 39 Gy Radiation Therapy (RADIATION), 32.5 Gy Radiation Therapy (RADIATION).
Who is sponsoring clinical trial NCT05120947?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.